Lebo Sun
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Circular RNAs in diseases
- Epigenetics and DNA Methylation
- RNA modifications and cancer
- Cancer-related gene regulation
- Polyamine Metabolism and Applications
- Extracellular vesicles in disease
Papers in
-
- Circular RNAs in diseases 5
- RNA modifications and cancer 5
- Epigenetics and DNA Methylation 3
- Polyamine Metabolism and Applications 3
- Cancer-related gene regulation 2
-
- MicroRNA in disease regulation 6
- Cancer-related molecular mechanisms research 6
- Co-authors
- Guofeng Shao (20 shared papers)Dawei Zheng (15 shared papers)Linwen Zhu (8 shared papers)Li Ni (2 shared papers)Guodong Xu (8 shared papers)Qingyun Zhou (5 shared papers)Ni Li (6 shared papers)Ni Li (10 shared papers)
- Journals
- BioMed Research International (4 papers)Bioscience Reports (2 papers)Scientific Reports (1 paper)Molecular Pharmaceutics (1 paper)Aging (1 paper)
- Partner nations
- China
In The Last Decade
Lebo Sun
20 papers receiving 420 citations
Peers
Comparison fields: 5 of 72
- Cancer Research 175
- Molecular Biology 325
- Cardiology and Cardiovascular Medicine 42
- Immunology 27
- Biochemistry 8
Countries citing papers authored by Lebo Sun
This map shows the geographic impact of Lebo Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lebo Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lebo Sun more than expected).
Fields of papers citing papers by Lebo Sun
This network shows the impact of papers produced by Lebo Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lebo Sun. The network helps show where Lebo Sun may publish in the future.
Co-authors
The 25 scholars most cited alongside Lebo Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 72 | |
| 2 | 2020 | 68 | |
| 3 | 2014 | 43 | |
| 4 | MicroRNA-9 regulates non-small cell lung cancer cell invasion and migration by targeting eukaryotic translation initiation factor 5A2. | 2017 | 36 |
| 5 | 2015 | 34 | |
| 6 | 2014 | 31 | |
| 7 | 2022 | 21 | |
| 8 | 2018 | 20 | |
| 9 | 2013 | 19 | |
| 10 | 2021 | 19 | |
| 11 | 2021 | 11 | |
| 12 | 2017 | 10 | |
| 13 | 2014 | 8 | |
| 14 | 2020 | 8 | |
| 15 | 2020 | 7 | |
| 16 | 2021 | 7 | |
| 17 | 2022 | 5 | |
| 18 | 2023 | 5 | |
| 19 | 2016 | 3 | |
| 20 | 2024 | 2 |
About Lebo Sun
Lebo Sun is a scholar working on Molecular Biology, Cancer Research, Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Surgery, having authored 21 papers that have together received 429 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (6 papers), Circular RNAs in diseases (5 papers), RNA modifications and cancer (5 papers), Epigenetics and DNA Methylation (3 papers), Polyamine Metabolism and Applications (3 papers), Pulmonary Hypertension Research and Treatments (2 papers) and Cancer-related gene regulation (2 papers). The work is most often cited by research in Cancer Research (175 citations), Molecular Biology (325 citations), Cardiology and Cardiovascular Medicine (42 citations), Immunology (27 citations) and Biochemistry (8 citations). Lebo Sun has collaborated with scholars based in China. Frequent co-authors include Guofeng Shao, Dawei Zheng, Linwen Zhu, Li Ni, Guodong Xu, Qingyun Zhou, Ni Li, Ni Li, Limin Xu and Qiaoling Pan. Their work appears in journals such as BioMed Research International, Bioscience Reports, Scientific Reports, Molecular Pharmaceutics and Aging.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.